Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (13)

2021

  1. Adipose tissue knockdown of lysozyme reduces local inflammation and improves adipogenesis in high-fat diet-fed mice

    Pharmacological Research, Vol. 166

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD

    FASEB Journal, Vol. 34, Núm. 9, pp. 11816-11837

2019

  1. Associations between neuropsychological performance and appetite-regulating hormones in anorexia nervosa and healthy controls: Ghrelin's putative role as a mediator of decision-making

    Molecular and Cellular Endocrinology, Vol. 497

  2. Reduced Plasma Orexin-A Concentrations are Associated with Cognitive Deficits in Anorexia Nervosa

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss

    Clinical Nutrition, Vol. 36, Núm. 3, pp. 861-868

  2. Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: Development of an FGF19-based chimeric molecule to promote fatty liver regeneration

    Gut, Vol. 66, Núm. 10, pp. 1818-1828

2016

  1. Decision making impairment: A shared vulnerability in obesity, gambling disorder and substance use disorders?

    PLoS ONE, Vol. 11, Núm. 9

  2. Enduring Changes in Decision Making in Patients with Full Remission from Anorexia Nervosa

    European Eating Disorders Review, Vol. 24, Núm. 6, pp. 523-527

  3. Interaction Between Orexin-A and Sleep Quality in Females in Extreme Weight Conditions

    European Eating Disorders Review, Vol. 24, Núm. 6, pp. 510-517

  4. Modulation of irisin and physical activity on executive functions in obesity and morbid obesity

    Scientific Reports, Vol. 6

  5. Orexin and sleep quality in anorexia nervosa: Clinical relevance and influence on treatment outcome

    Psychoneuroendocrinology, Vol. 65, pp. 102-108

2014

  1. Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in β-cells

    International Journal of Obesity, Vol. 38, Núm. 12, pp. 1545-1554